Cracking Cloning

Cracking Cloning Nuclear transfer research encompasses some of the most compelling biological and ethical puzzles of our time. In an online publishing experiment, we asked you, The Scientist readers, to help us create the article. Here's how you would solve the mysteries of the egg, fertilization, and cloning. By The Readers and Editors of The Scientist Related Articles 1. The guidelines were similar, but differed in how research should be overseen. Still, say Leo

Written byThe Readers and Editors of The Scientist
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

By The Readers and Editors of The Scientist

1. The guidelines were similar, but differed in how research should be overseen. Still, say Leonard Zon and colleagues at the Children's Hospital Boston Stem Cell Program, in a post to our Web discussion, "Debate continues around the world about when monetary incentives may become an undue factor in a woman's decision to donate."

Kevin Eggan, from Harvard, says he's aggravated with what he perceives as a double standard. In the Spring of last year, he and Doug Melton received approval for human nuclear transfer experiments. But while fertility clinics routinely provide financial incentive for donors Eggan's team was barred from doing so. Expenses such as child care and travel can be covered, but protocols are scrutinized for anything that might be considered "undue inducement." "Doug and I have spent more than $50,000 on advertising in the last year and many hundreds ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies